Artificial Intelligence Powered Mental Health Support Tool For Physicians In Training
Launched by CEDARS-SINAI MEDICAL CENTER · Jul 17, 2025
Trial Information
Current as of July 27, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is testing a new mental health support tool that uses artificial intelligence (AI) to help doctors in training manage feelings of depression and anxiety. The tool is accessed through a web browser and offers mental health support sessions designed to improve overall wellness. The study aims to see how well this AI tool is accepted and whether it helps reduce symptoms of depression and anxiety by comparing survey results taken before and after using the tool.
The study is open to doctors who are currently training in Internal Medicine or Gastroenterology at Cedars-Sinai, are 18 years or older, and speak English. Participants will take part in at least four sessions over about three months, answering simple questionnaires about their mood and anxiety levels before and after using the tool. People who are currently receiving treatment for severe or uncontrolled anxiety or depression, or those who cannot participate in English, are not eligible. This study is not yet recruiting participants but offers a promising way to support the mental health of physicians in training using innovative technology.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Individuals 18 years old or older are included.
- • Training physicians in Internal Medicine residency and Gastroenterology fellowship at Cedars Sinai.
- • Study is limited to Cedars-Sinai employees who are known to speak English.
- Exclusion Criteria:
- • Active treatment of severe and uncontrolled anxiety or depression with a health care professional
- • Unwilling and or unable to participate
- • Non-English speakers.
About Cedars Sinai Medical Center
Cedars-Sinai Medical Center is a renowned nonprofit academic medical center located in Los Angeles, California, recognized for its commitment to patient care, research, and education. As a leading institution in clinical trials, Cedars-Sinai harnesses innovative approaches to advance medical knowledge and improve treatment outcomes across various specialties. With a multidisciplinary team of experts, state-of-the-art facilities, and a patient-centered approach, Cedars-Sinai actively contributes to the development of novel therapies and interventions, ensuring the highest standards of clinical research while prioritizing patient safety and ethical considerations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Los Angeles, California, United States
Patients applied
Trial Officials
Kavya Reddy, MD
Principal Investigator
Cedars-Sinai Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported